Results 191 to 200 of about 31,032 (201)

Letrozole

Reactions Weekly, 2002
openaire   +1 more source

Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

Journal of Clinical Oncology, 2008
Giuseppe Viale, Meredith M Regan, Scd, Alan S Coates   +2 more
exaly  

Letrozole

Reactions Weekly, 2009
openaire   +1 more source

Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial

Lancet Oncology, The, 2018
Per Karsson, Jacquie Chirgwin, Stefan Aebi   +2 more
exaly  

Overall Survival With Palbociclib Plus Letrozole in Advanced Breast Cancer

Journal of Clinical Oncology
Dennis J Slamon, Hope S Rugo, Nadia Harbeck   +2 more
exaly  

Letrozole

Reactions Weekly, 2015
  +4 more sources

Letrozol

2013
openaire   +1 more source

Letrozole

2007
openaire   +1 more source

Phase III Study of Letrozole Versus Tamoxifen as First-Line Therapy of Advanced Breast Cancer in Postmenopausal Women: Analysis of Survival and Update of Efficacy From the International Letrozole Breast Cancer Group

Journal of Clinical Oncology, 2003
exaly  

Letrozole

Inpharma Weekly, 1998
openaire   +1 more source